Science | ABNewswire

Warm Autoimmune Hemolytic Anemia Market Size in the 7MM was ~300 Million in 2023 and it is expected to grow by 2034, estimates DelveInsight

DelveInsight’s “Warm Autoimmune Hemolytic Anemia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Warm Autoimmune Hemolytic Anemia, historical and forecasted epidemiology and the Warm Autoimmune Hemolytic Anemia market trends in the United States, … Continue reading →

Caregiver Sleep Study Finds 70% of Parents Wake Every Night; Mothers Spend 50% More Time Awake Than Fathers

“Caregiver sleep disruption isn’t just a phase or a minor inconvenience,” said Shimin Ooi, CEO of Sleep Reset. “The combination of frequent awakenings, stress, and irregular schedules puts caregivers, especially mothers, at elevated risk for serious physical and mental health … Continue reading →

Follicular Lymphoma Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Follicular Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Fabry Disease Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Fabry Disease Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in the Fabry Disease pipeline landscape. It covers the Fabry Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Paroxysmal Nocturnal Hemoglobinuria Market Size is projected to grow at a CAGR of 7.1% by 2034, estimates DelveInsight

DelveInsight’s “Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Paroxysmal Nocturnal Hemoglobinuria, historical and forecasted epidemiology and the Paroxysmal Nocturnal Hemoglobinuria market trends in the United States, EU4 (Germany, France, … Continue reading →

Hidradenitis Suppurativa Market Size in the 7MM was ~USD ~1,400 Million in 2023 and It is expected to grow by 2034, estimates DelveInsight

DelveInsight’s “Hidradenitis Suppurativa Market Insight, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of hidradenitis suppurativa, historical and forecasted epidemiology, as well as the hidradenitis suppurativa market trends in the United States, EU4 (Germany, France, Italy, and … Continue reading →

Polymyalgia Rheumatica Treatment Market Size in the 7MM is projected to grow by 2034, estimates DelveInsight

DelveInsight’s “Polymyalgia Rheumatica Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Polymyalgia Rheumatica, historical and forecasted epidemiology and the Polymyalgia Rheumatica market trends in the United States, EU4 (Germany, France, Italy, and Spain) … Continue reading →

Gorlin Syndrome Clinical Trial Pipeline Shows Potential with Active Contributions from 5+ Key Companies | DelveInsight

DelveInsight’s, “Gorlin Syndrome Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Gorlin Syndrome pipeline landscape. It covers the Gorlin Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Howard Bloom and The Howard Bloom Institute: Charting the Future of Human Thought

Visionary author, cultural theorist, and futurist Howard Bloom continues to challenge, provoke, and illuminate global conversations through his groundbreaking work and the mission of The Howard Bloom Institute—a think tank dedicated to exploring the forces that shape human behavior, innovation, … Continue reading →

New Report Finds 94% of German Mittelstand Firms Still Without AI Implementation

German SMEs are delaying AI adoption for governance reasons, the competitiveness gap widens every quarter. New research from Dr Justus & Partners reveals that 94% of German Mittelstand firms have not implemented AI, with leadership hesitation and skills shortages – … Continue reading →

Friday - February 06, 2026

Category Archives: Science